Search images on Google Product Monograph
Active Ingredients:
- deferoxamine mesylate, 2 G/VIAL
DIN: 02247022
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAMUSCULAR, INTRAPERITONEAL, INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
ATC:
- V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
- V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
- V03AC - Iron chelating agents (ATC, WHO)
- V03AC01 - DEFEROXAMINE (WHO)
Reference brand drug: Desferal
Pharmaceutical standard: MFR